Clinical Trial Update: Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluating the combination of docetaxel, gemcitabine, and a G-CSF (filgrastim) or pegfilgrastim in patients with advanced, persistent,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Leiomyosarcoma

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Filgrastim (filgrastim)
• Gemcitabine (Gemcitabine)
• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Sarcoma | Phase 2 | Status: COMPLETED